Children with Higher Intelligence Less Likely to Report Chronic Widespread Pain in Adulthood
New Study Tracked Nearly 7000 Men and Women from Age 11 to 45, Reports PAIN®
Philadelphia, PA, November 29, 2012 – A UK-based study team has determined that there is a correlation between childhood intelligence and chronic widespread pain (CWP) in adulthood, according to a new study published in the December issue of PAIN®. About 10-15 percent of adults report CWP, a common musculoskeletal complaint that tends to occur more frequently among women and those from disadvantaged socioeconomic backgrounds. CWP is a core symptom of fibromyalgia and is one of the most common reasons for consulting a rheumatologist.
“One psychological factor that could potentially be a risk factor for CWP in adult life is lower cognitive ability in youth,” says lead researcher Dr Catharine R. Gale, MRC Lifecourse Epidemiology Unit, University of Southampton, UK, and Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK. “Our hypotheses were that men and women who scored lower on the test of intelligence in childhood would have an increased risk of CWP in midlife and that some of this association would be mediated through socioeconomic status, mental health, or lifestyle factors in adulthood.”
The investigators used data from the National Child Development Survey, an ongoing cohort study originally based on over 17,000 live births in Great Britain during one week in 1958. When cohort members were aged 11 years, they completed a test of intelligence. At the age of 45 years, 6902 cohort members took part in a biomedical survey during which they completed a questionnaire to assess the presence of chronic widespread pain (CWP).
CWP was found among 14.4 percent of the participants. Men and women with CWP scored significantly lower on the test of intelligence at age 11. They were also more likely to have manual jobs, to be a current or ex-smoker, to have a higher body mass index, and to report higher levels of psychological distress.
The study concluded that men and women with lower intelligence at age 11 are more likely to report CWP.
Says Gale, “To our knowledge, this is the first study to investigate the prospective relation between intelligence and CWP. Our results show that individuals with higher intelligence in childhood are less likely as adults to develop this common and disabling condition. We now need to understand the mechanisms causing this association.”
In a commentary accompanying the article, Eva M. Kingma and Judith G.M. Rosmalen of the Interdisciplinary Center Psychopathology and Emotion Regulation University Medical Center Groningen, The Netherlands say: “Although an association between chronic pain and cognitive ability has been shown before, the Gale et al. report is the first longitudinal study in a large general population cohort. Two important characteristics stand out in their study. First, its longitudinal design enabled the researchers to study causal direction as well as interesting explanatory mechanisms in the association between intelligence and pain. Second, the study used a population-based design, which contrasts with many previous etiological studies that compared patients to healthy controls. This approach is especially relevant because CWP is much more prevalent than clinical data on fibromyalgia suggest.
# # #
Notes for editors
“Intelligence in childhood and chronic widespread pain in middle age: The National Child Development Survey,” by Catharine R. Gale, Ian J. Deary, Cyrus Cooper, G. David Batty (DOI: 10.1016/j.pain.2012.07.027).
“The power of longitudinal population-based studies for investigating the etiology of chronic widespread pain,” by E.M. Kingma and J.G.M. Rosmalen (DOI: 10.1016/j.pain.2012.09.001).
They appear in PAIN, Volume 153, Issue 12 (December 2012) published by Elsevier.
Full text of the articles is available to credentialed journalists upon request. Contact Christine Rullo at +1 215 239 3709 or firstname.lastname@example.org for copies. Journalists wishing to set up interviews should contact Dr Catharine Gale at +44 2380 764080 or +44 131 650 3348 and via email at email@example.com.
The University of Edinburgh Centre for Cognitive Ageing and Epidemiology (CCACE; www.ccace.ed.ac.uk) is funded by the Lifelong Health and Wellbeing programme, a collaboration between the UK’s Research Councils and Health Departments which is led by the MRC (www.mrc.ac.uk/LLHW).
PAIN®, the official journal of the International Association for the Study of Pain® (IASP®), publishes 12 issues per year of original research on the nature, mechanisms, and treatment of pain. This peer-reviewed journal provides a forum for the dissemination of research in the basic and clinical sciences of multidisciplinary interest and is cited in Current Contents and MEDLINE. It is ranked 1st out of the 28 journals in the Anesthesiology category according to the 2011 Journal Citation Reports published by Thomson Reuters. www.painjournalonline.com
About The International Association for the Study of PAIN® (IASP®)
Founded in 1973, IASP® is the world's largest multidisciplinary organization focused specifically on pain research and treatment. It is the leading professional forum for science, practice, and education in the field of pain bringing together scientists, clinicians, health care providers, and policy makers to stimulate and support the study of pain and to translate that knowledge into improved pain relief worldwide. IASP currently has more than 7500 members from 130 countries and in 87 chapters. www.iasp-pain.org
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+1 215 239 3709